Evaluating the Effectiveness of a Cognitive Behavioral Intervention (CBI)

Sponsor
Howard University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05782348
Collaborator
Temple University (Other)
150
1
3
16.8
9

Study Details

Study Description

Brief Summary

This is a Phase III, randomized, one-center, three arm parallel group, open label and single blind clinical study to evaluate the effectiveness of a cognitive behavioral intervention (CBI) adjunctive to a smart powered toothbrush on the oral health of adolescents.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cognitive behavioral intervention
  • Other: Colgate smart toothbrush
N/A

Detailed Description

This is a Phase III, randomized, one-center, three arm parallel group, open label and single blind clinical study to evaluate the effectiveness of a cognitive behavioral intervention (CBI) adjunctive to a smart powered toothbrush on the oral health of adolescents. Outcomes briefly summarized include the plaque score, gingival score and a survey of knowledge, attitudes and procedures measured at 1,3 and 6 months

Participating subjects will be randomized to one of the following products:

TEST GROUP I A commercially available fluoride toothpaste (1450 ppm F) A commercially available Smart Electric toothbrush CONTROL GROUP I A commercially available fluoride toothpaste (1450 ppm F) A commercially available Smart Electric toothbrush CONTROL GROUP II A commercially available fluoride toothpaste (1450 ppm F) A commercially available soft bristle toothbrush

Study Design

Study Type:
Interventional
Anticipated Enrollment :
150 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Three arm parallel group single blind studyThree arm parallel group single blind study
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Clinical Study to Evaluate the Effectiveness of a Cognitive Behavioral Intervention (CBI) Adjunctive to a Smart Powered Toothbrush on the Oral Health of Adolescents
Actual Study Start Date :
Feb 6, 2023
Anticipated Primary Completion Date :
Feb 6, 2024
Anticipated Study Completion Date :
Jun 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Test Group I

A commercially available fluoride toothpaste (1450 ppm F) A commercially available Smart Electric toothbrush Cognitive behavioral intervention (CBI)

Behavioral: Cognitive behavioral intervention
A six-session CBI Intervention component will be used with the TEST GROUP I. This will examine a cognitive behavioral intervention designed to improve tooth brushing and oral hygiene. The components include oral health education, values-based activities, motivational interviewing, goal setting, problem solving skills, cognitive restructuring, verbal reinforcement and stress management.

Other: Colgate smart toothbrush
A Colgate smart toothbrush that provides the user with details on toothbrushing habits and frequency

Active Comparator: Control group I

A commercially available fluoride toothpaste (1450 ppm F) A commercially available Smart Electric toothbrush

Other: Colgate smart toothbrush
A Colgate smart toothbrush that provides the user with details on toothbrushing habits and frequency

No Intervention: Control group II

A commercially available fluoride toothpaste (1450 ppm F) A commercially available soft bristle toothbrush

Outcome Measures

Primary Outcome Measures

  1. Gingival inflammation [All outcomes will be measured at baseline, at1 month, 3 months and at 6 months]

    A Löe-Silness Gingival Index score from 0 to 3 will be assigned by the examining dentist to all scorable surfaces of the maxillary and mandibular teeth using a dental light and dental mirror. A whole mouth mean score for each subject will be determined by adding the values given by the examining dentist to each scorable surface and dividing that number by the total number of surfaces scored. Scores Criteria 0 Absence of inflammation Mild inflammation- Slight change in color and mild edema with little change in texture. No bleeding on probing. Moderate inflammation- moderate glazing, redness, edema and hypertrophy. Bleeding on probing. Severe inflammation- Marked redness, hypertrophy, edema and ulceration. Tendency for spontaneous bleeding.

Secondary Outcome Measures

  1. Plaque scores [All outcomes will be measured at baseline, 1 month, 3 months and at 6 months]

    Mean plaque index scores will be computed for each subject. Each tooth is scored in six areas: 1) mesio-facial; 2) mid-facial; 3) disto-facial; 4) mesio-lingual; 5) mid-lingual; and 6) disto-lingual. Whole mouth within subject mean scores will be computed as follows: Total plaque score for all scoring sites divided by total number of scoring sites

  2. Knowledge assessment [All outcomes will be measured at baseline, 1 month, 3 months and at 6 months]

    Knowledge will be assessed using 19 item scale previously used by the researchers Enrolled subjects will complete a questionnaire on oral health knowledge, attitudes, and practices including: frequency of brushing and flossing, knowledge, oral health values scale, self-efficacy and motivation. The outcome will be assessed using a 19-item multiple choice survey previously used in Colgate-sponsored research protocols. A six-item oral health self-efficacy scale will be used to measure participant self-reported confidence in their ability to carry out an oral health care routine. Lastly, motivation to engage in recommended oral hygiene behavior will be assessed with a single item 1analog scale (i.e., "How important is it to follow guidelines for brushing twice per day and flossing once per day, from 0 "not important at all" to 10 "most important.")

  3. Efficacy assessment [All outcomes will be measured at baseline, 1 month, 3months and at 6 months]

    Efficacy will be assessed using a validated 6 item oral health self-efficacy scale

  4. Motivation assessment [All outcomes will be measured at baseline, 1 month, 3months and at 6 months]

    Motivation will be assessed using a single item 10-point visual analog scale

Eligibility Criteria

Criteria

Ages Eligible for Study:
14 Years to 17 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

Students are enrolled in participating high schools Caregivers give informed consent Student gives assent

Exclusion Criteria:
  • Having a prosthetic heart valve

  • Having a history of previously having infective endocarditis

  • Having had joint replacement surgery

  • Children on blood thinner medication such as Coumadin or Rivaroxaban

  • Children who are currently receiving chemotherapy

  • Children who have received organ transplants of any type

  • Children with Leukemia

Contacts and Locations

Locations

Site City State Country Postal Code
1 Friendship Public Charter School Washington District of Columbia United States 20059

Sponsors and Collaborators

  • Howard University
  • Temple University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Brian Laurence, Professor, Howard University
ClinicalTrials.gov Identifier:
NCT05782348
Other Study ID Numbers:
  • CRO-2022-10-CBT-HU-US-BS
First Posted:
Mar 23, 2023
Last Update Posted:
Mar 23, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Brian Laurence, Professor, Howard University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 23, 2023